clientservices@aitlabs.com :: 800-875-3894

DetectiMed® Panel

Your partner in therapy management

Better information leads to better outcomes. AIT’s DetectiMed^® Panel is designed to help physicians make objective, informed decisions regarding patient care. Whether you are performing a baseline evaluation, monitoring compliance, or adjusting a treatment plan, DetectiMed is a powerful tool for any practice.

DetectiMed uses an immunoassay screen to determine the presence of drugs featured in a dozen general drug classes, including:

Alcohol
Amphetamines
Barbiturates
Benzodiazepines
Cannabinoids
Cocaine
Fentanyl
Methadone
Opiates
Phencyclidine
Propoxyphene

AIT validates each specimen by testing for adulterants and detecting metabolites to verify ingestion.

A confirmation test is performed on all positive screens, providing unambiguous identification and quantitation of all substances present in the specimen.

Results in as little as 72 hours, including quantitative confirmation on positive samples.

View our panels for urine and blood here.

For more information about AIT’s DetectiMed Panel, contact our Client Services Department or search for a sales representative in your state.

Check out the newest field research published by AIT staff. Visit Expert Research

AIT’s instrumentation is more sensitive and more diverse than most testing labs in the country. Visit Technology